GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomarin Pharmaceutical Inc (FRA:BM8) » Definitions » Other Assets for Insurance Companies

Biomarin Pharmaceutical (FRA:BM8) Other Assets for Insurance Companies


View and export this data going back to 1999. Start your Free Trial

What is Biomarin Pharmaceutical Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Biomarin Pharmaceutical Business Description

Industry
Address
770 Lindaro Street, San Rafael, CA, USA, 94901
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.